![](https://www.albimmune.com/wp-content/uploads/2022/10/albumim-logo-300x112.png)
About
Human albumin treatment in adult septic shock. A phase 2, multicenter, randomized, placebo-controlled study evaluating the immune response and organ failure.
![](https://www.albimmune.com/wp-content/uploads/2022/12/albumim-description-768x824.png)
Description
- To assess if albumin treatment increases B cell gene expression, as estimated by the immunoglobulin complex gene set (ICGS) score, in non-cirrhotic patients with septic shock
- To investigate potential mechanisms of this effect
![](https://www.albimmune.com/wp-content/uploads/2022/12/icon-sepsis-150x150.png)
Non-cirrhotic patients hospitalized with sepsis
Centers
![](https://www.albimmune.com/wp-content/uploads/2022/12/albumim-centers-1024x766.png)
Barcelona, Spain
- Hospital Clínic de Barcelona
- Hospital de la Santa Creu i Sant Pau
- Hospital Universitari Vall d’Hebron
Madrid, Spain
- Hospital Universitario de Getafe
Sabadell, Spain
- Hospital Universitari Parc Taulí de Sabadell